Continuous Manufacturing Market is estimated to be worth around USD 2 billion in 2030

Roots
Analysis is pleased to announce the publication of its recent study, titled, “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 –
2030.” 

The
report features an extensive study of the current market landscape and future
opportunities for companies with capabilities in continuous manufacturing (both
innovator companies with in-house expertise and contract manufacturers). It
features an in-depth analysis, highlighting the capabilities of various
stakeholders engaged in this domain. In addition to other elements, the study
includes:

·       
A  detailed
assessment of the overall landscape of companies with capabilities for
continuous manufacturing

·       
Elaborate profiles of some of the key
contract manufacturers active in the pharmaceutical and biopharmaceutical
continuous manufacturing market

·       
An analysis of the various partnerships
related to continuous manufacturing, which have been established since 2013

·       
An analysis of the expansions related to
continuous manufacturing, which have been established since 2013

·       
An estimate of the global, continuous manufacturing
capacity, based on the capacities of various industry stakeholders (as
available on their respective company websites).

·       
A study of the various grants that have been
awarded to research institutes engaged in projects related to continuous
manufacturing, between 2014 and 2019

·       
An in-depth analysis of the various patents
that have been filed / granted related to continuous manufacturing till 2019

·       
Initiatives taken by the leading
pharmaceutical companies (in terms of revenues), covering both partnered as
well as in-house projects.

·       
A review of the companies offering modular
facilities / modular cleanrooms

·       
A case study of the companies offering
technologies / equipment

·       
A case study on the roadmap for the adoption
of continuous manufacturing technique